NUTX
Nutex Health Inc
NASDAQ · Health Care
$99.90
-2.07 (-2.03%)
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 631.71M | 211.30M | 206.51M | 228.52M |
| Net Income | 68.68M | 33.06M | 32.39M | 29.97M |
| EPS | — | — | — | — |
| Profit Margin | 10.9% | 15.7% | 15.7% | 13.1% |
| Rev Growth | +194.5% | -0.3% | -4.7% | +6.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 239.36M | 220.72M | 209.66M | 183.59M |
| Total Equity | 113.88M | 539.73M | 559.50M | 599.03M |
| D/E Ratio | 2.10 | 0.41 | 0.37 | 0.31 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 195.66M | 53.46M | 50.14M | 59.71M |
| Free Cash Flow | — | 26.76M | 25.55M | 48.32M |